Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	1637.25	618.37	35.59
Graham Fair Price	-28.31	0.14	0.20
PEG	100.00	0.56	0.00
Price/Book	37.16	2.98	2.17
Price/Cash Flow	15.53	106.37	92.08
Prices/Earnings	363.97	-66.57	14.35
Price/Sales	-28.26	2.50	3.49
Price/FCF	15.53	106.37	92.08
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	-55.49	0.06	0.14
Operating Margin	-86.76	< 0.005	0.07
ROA	-69.97	< 0.005	0.03
ROE	0.04	-0.01	-70.44
ROIC	0.03	-0.01	-56.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.95	0.00	100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-1.13	-100.00
EPS QOQ	0.00	-1.20	-100.00
FCF QOQ	0.00	-0.41	-100.00
Revenue QOQ	0.00	-0.05	-100.00
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.52	-6.28	1117.86
Days Sales Outstanding (DSO)	146.33	60.81	-58.45
Inventory Turnover	174.45	-14.32	-91.79
Debt/Capitalization	< 0.005	< 0.005	96.65
Quick Ratio	3.22	2.94	-8.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.22	0.28	31.86
Cash	0.07	0.11	41.82
Capex	< 0.005	< 0.005	-53.33
Free Cash Flow	< 0.005	< 0.005	56.54
Revenue	0.13	0.34	152.10
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	3.22	3.36	4.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.38	-65.64	-1399.93
Naive Interpretation	Member

06 - Financial Health · Bad

Rating